<p>Comerica Bank 在最近向 SEC 提交的文件中表示，在第三季度将其在 Stryker Corporation (NYSE:SYK - 免费报告) 的持股减少了 2.6%。该基金在季度内出售了 3,307 股后，持有该医疗科技公司 122,337 股股票。截至最近向 SEC 提交的文件，Comerica Bank 在 Stryker 的持股价值为 45,224,000 美元。</p>
<ul>
<li>三家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
<p>其他几家对冲基金和机构投资者也调整了对该公司的持股。Clayton Financial Group LLC 在第三季度以约 26,000 美元的价格购买了 Stryker 的新头寸。Elevation Point Wealth Partners LLC 在第二季度以约 28,000 美元的价格购买了 Stryker 的新头寸。Kilter Group LLC 在第二季度以约 29,000 美元的价格购买了 Stryker 的新头寸。霍华德·休斯医学研究所（Howard Hughes Medical Institute）在第二季度以约 29,000 美元的价格收购了 Stryker 的新股份。最后，United Financial Planning Group LLC 在第三季度以约 27,000 美元的价格购买了 Stryker 的新股份。77.09% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师设定新目标价</h2>
<p>一些研究分析师最近对 SYK 股票发布了报告。Weiss Ratings 在 12 月 22 日的研究报告中重申了对 Stryker 股票的 &#34;持有（c+）&#34; 评级。瑞银集团将 Stryker 的目标价从 386.00 美元上调至 400.00 美元，并在 2 月 24 日的研究报告中给予该股票 &#34;中性&#34; 评级。Sanford C. Bernstein 在 1 月 9 日的研究报告中将 Stryker 的目标价从 450.00 美元上调至 465.00 美元，并给予该公司 &#34;跑赢大盘&#34; 评级。Truist Financial 在 12 月 18 日的报告中将 Stryker 股票的目标价从 400.00 美元下调至 392.00 美元，并为该公司设定了 &#34;持有&#34; 评级。最后，富国银行将 Stryker 股票的目标价从 452.00 美元上调至 456.00 美元，并在 11 月 14 日的报告中给予该股票 &#34;超配&#34; 评级。十四位研究分析师对该股票给予了买入评级，五位分析师对该公司的股票给予了持有评级。根据 MarketBeat 的数据，该股票目前的共识评级为 &#34;适度买入&#34;，共识目标价为 428.61 美元。</p>
<ul>
<li>为什么内部人士正在抛售 Robinhood、Stryker 和 Mercury Systems 的股票？</li>
</ul>
<p><strong>获取我们关于 Stryker 的最新股票报告</strong></p>
<h2>Stryker 股票下跌 0.1%</h2>
<p>SYK 股票在周五开盘价为 336.95 美元。Stryker Corporation 的一年低点为 328.23 美元，一年高点为 404.87 美元。该公司的市值为 1289.5 亿美元，市盈率为 40.11，市盈率增长比率为 1.97，贝塔系数为 0.85。该股票的 50 日移动平均线为 365.20 美元，200 日移动平均线为 367.71 美元。该公司的债务与股本比率为 0.66，速动比率为 1.21，流动比率为 1.89。</p>
<ul>
<li>当心死亡交叉：3 只触发这一可怕信号的股票</li>
</ul>
<p>Stryker (NYSE:SYK - 获取免费报告) 最近在 1 月 29 日发布了季度财报。该医疗科技公司报告季度每股收益为 4.47 美元，超出分析师一致预期的 4.40 美元，超出幅度为 0.07 美元。Stryker 的股本回报率为 24.41%，净利润率为 12.92%。该公司季度收入为 71.7 亿美元，而分析师预期为 71.2 亿美元。去年同期，该公司每股收益为 4.01 美元。与去年同期相比，该公司的季度收入增长了 11.4%。整体而言，研究分析师预计 Stryker Corporation 本年度将发布 13.47 美元的每股收益。</p>
<h2>Stryker 股息公告</h2>
<p>该公司最近还宣布了一项季度股息，将于 4 月 30 日支付。3 月 31 日的股东将获得每股 0.88 美元的股息。该股息的除息日期为 3 月 31 日。这代表着年化股息为 3.52 美元，收益率为 1.0%。Stryker 的股息支付比率（DPR）目前为 41.90%。</p>
<h2>Stryker 的内部活动</h2>
<p>在其他新闻中，董事 Ronda E. Stryker 于 2 月 4 日星期三出售了 250,000 股公司的股票，交易价格为每股平均 362.92 美元，总价值为 90,730,000.00 美元。出售完成后，该董事直接持有公司 2,457,331 股股票，价值约为 891,814,566.52 美元。这代表着其持股减少了 9.23%。该交易在向 SEC 提交的法律文件中披露，文件可通过此链接访问。公司内部人士持有公司 5.90% 的股票。</p>
<h2>关于 Stryker 的热门头条</h2>
<p>以下是本周影响 Stryker 的关键新闻故事：</p>
<ul>
<li>积极情绪：花旗和一些分析师认为此次回调是一个潜在的买入机会，考虑到史赛克的基本面和即将到来的催化剂——花旗制定了一个 “90 天催化剂观察”，认为尽管出现故障，仍有上涨空间。花旗看好前景</li>
<li>积极情绪：技术面可能提供支撑：评论人士指出，股票在抛售后变得超卖，并在之前的水平找到支撑，暗示交易者可能会出现技术性反弹。今日股票：史赛克的底部在哪里？</li>
<li>中性情绪：史赛克已公开确认发生网络安全事件，并正在调查；公司正在随着情况的发展进行更新沟通。公司公告</li>
<li>中性情绪：报告显示此次攻击对订单处理、制造和发货造成了实际的运营干扰——投资者必须关注这些事实，以判断持续时间和收入影响。路透社：干扰报告</li>
<li>消极情绪：声称与伊朗有关的黑客（“Handala” 组织）表示此次攻击包括破坏性的 “清除” 行为和大量数据的外泄——这些指控增加了延长停机时间和监管/公关后果的风险。国际财经时报：黑客声明</li>
<li>消极情绪：事件导致的运营瘫痪已经对股票施加压力，多家媒体报道订单和发货停滞，股价出现多个百分点的日内下跌。雅虎：股价下跌</li>
<li>消极情绪：社交媒体驱动的抛售加剧了波动性——一条病毒式传播的 Reddit 帖子及相关头条加速了近期的下跌，增加了超出基本面的短期下行风险。24/7 Wall St.：Reddit 影响</li>
</ul>
<h2>史赛克简介</h2>
<p>(免费报告)</p>
<p>史赛克公司是一家全球医疗技术公司，设计、制造和销售广泛的产品和服务，供医院、外科医生办公室和其他医疗机构使用。其主要业务活动涵盖骨科（包括关节置换植入物、创伤和四肢产品）、外科设备和手术室技术（如可视化、导航和电动工具）、神经技术和脊柱解决方案，以及病人搬运和紧急医疗设备。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票</li>
<li>马丁·韦斯的个人警告（请阅读）</li>
<li>SpaceX IPO 确认：今天认领你的股份</li>
<li>伊朗并不是真正的战争</li>
<li>这枚硬币一切都在向好发展</li>
<li>今天仅限 500 人…</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在史赛克吗？</h2>
<p>在你考虑史赛克之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而史赛克并不在名单上。</p>
<p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

史赛克

标普健康医疗设备 ETF - SPDR

美国医药设备 ETF - iShares

<p>Comerica Bank 在第三季度将其在史赛克（NYSE:SYK）的持股减少了 2.6%，目前持有 122,337 股，价值为 4520 万美元。几家机构投资者也调整了他们的持仓。分析师为史赛克设定的共识目标价为 428.61 美元，评级为 “适度买入”。该股票开盘价为 336.95 美元，市值为 1289.5 亿美元。史赛克最近宣布每股季度股息为 0.88 美元，收益率为 1.0%。内部人士 Ronda E. Stryker 出售了 250,000 股，减少了她的持股比例 9.23%</p>

<p>Comerica Bank reduced its holdings in Stryker Corporation (NYSE:SYK - Free Report) by 2.6% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 122,337 shares of the medical technology company's stock after selling 3,307 shares during the quarter. Comerica Bank's holdings in Stryker were worth $45,224,000 as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>Comerica Bank 在最近向 SEC 提交的文件中表示，在第三季度将其在 Stryker Corporation (NYSE:SYK - 免费报告) 的持股减少了 2.6%。该基金在季度内出售了 3,307 股后，持有该医疗科技公司 122,337 股股票。截至最近向 SEC 提交的文件，Comerica Bank 在 Stryker 的持股价值为 45,224,000 美元。</p>
</div><ul>
<li>3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most</li>
</ul>
<div class="lb-trans"><ul>
<li>三家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
</div><p>Several other hedge funds and other institutional investors have also modified their holdings of the business. Clayton Financial Group LLC bought a new position in Stryker in the third quarter worth about $26,000. Elevation Point Wealth Partners LLC bought a new position in shares of Stryker during the second quarter valued at approximately $28,000. Kilter Group LLC bought a new position in shares of Stryker during the second quarter valued at approximately $29,000. Howard Hughes Medical Institute acquired a new stake in shares of Stryker during the 2nd quarter worth approximately $29,000. Finally, United Financial Planning Group LLC bought a new stake in shares of Stryker in the 3rd quarter worth approximately $27,000. 77.09% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者也调整了对该公司的持股。Clayton Financial Group LLC 在第三季度以约 26,000 美元的价格购买了 Stryker 的新头寸。Elevation Point Wealth Partners LLC 在第二季度以约 28,000 美元的价格购买了 Stryker 的新头寸。Kilter Group LLC 在第二季度以约 29,000 美元的价格购买了 Stryker 的新头寸。霍华德·休斯医学研究所（Howard Hughes Medical Institute）在第二季度以约 29,000 美元的价格收购了 Stryker 的新股份。最后，United Financial Planning Group LLC 在第三季度以约 27,000 美元的价格购买了 Stryker 的新股份。77.09% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>A number of research analysts recently issued reports on SYK shares. Weiss Ratings restated a &#34;hold (c+)&#34; rating on shares of Stryker in a research report on Monday, December 22nd. UBS Group increased their target price on Stryker from $386.00 to $400.00 and gave the stock a &#34;neutral&#34; rating in a research report on Tuesday, February 24th. Sanford C. Bernstein raised their target price on Stryker from $450.00 to $465.00 and gave the company an &#34;outperform&#34; rating in a research note on Friday, January 9th. Truist Financial reduced their price target on shares of Stryker from $400.00 to $392.00 and set a &#34;hold&#34; rating for the company in a report on Thursday, December 18th. Finally, Wells Fargo &amp; Company increased their price objective on shares of Stryker from $452.00 to $456.00 and gave the stock an &#34;overweight&#34; rating in a report on Friday, November 14th. Fourteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $428.61.</p>
<div class="lb-trans"><p>一些研究分析师最近对 SYK 股票发布了报告。Weiss Ratings 在 12 月 22 日的研究报告中重申了对 Stryker 股票的 &#34;持有（c+）&#34; 评级。瑞银集团将 Stryker 的目标价从 386.00 美元上调至 400.00 美元，并在 2 月 24 日的研究报告中给予该股票 &#34;中性&#34; 评级。Sanford C. Bernstein 在 1 月 9 日的研究报告中将 Stryker 的目标价从 450.00 美元上调至 465.00 美元，并给予该公司 &#34;跑赢大盘&#34; 评级。Truist Financial 在 12 月 18 日的报告中将 Stryker 股票的目标价从 400.00 美元下调至 392.00 美元，并为该公司设定了 &#34;持有&#34; 评级。最后，富国银行将 Stryker 股票的目标价从 452.00 美元上调至 456.00 美元，并在 11 月 14 日的报告中给予该股票 &#34;超配&#34; 评级。十四位研究分析师对该股票给予了买入评级，五位分析师对该公司的股票给予了持有评级。根据 MarketBeat 的数据，该股票目前的共识评级为 &#34;适度买入&#34;，共识目标价为 428.61 美元。</p>
</div><ul>
<li>Why Are Insiders Are Dumping Shares of Robinhood, Stryker, and Mercury Systems?</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么内部人士正在抛售 Robinhood、Stryker 和 Mercury Systems 的股票？</li>
</ul>
</div><p><strong>Get Our Latest Stock Report on Stryker</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 Stryker 的最新股票报告</strong></p>
</div><h2>Stryker Trading Down 0.1%</h2>
<div class="lb-trans"><h2>Stryker 股票下跌 0.1%</h2>
</div><p>Shares of SYK stock opened at $336.95 on Friday. Stryker Corporation has a 1 year low of $328.23 and a 1 year high of $404.87. The firm has a market capitalization of $128.95 billion, a PE ratio of 40.11, a price-to-earnings-growth ratio of 1.97 and a beta of 0.85. The stock has a fifty day moving average of $365.20 and a two-hundred day moving average of $367.71. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.21 and a current ratio of 1.89.</p>
<div class="lb-trans"><p>SYK 股票在周五开盘价为 336.95 美元。Stryker Corporation 的一年低点为 328.23 美元，一年高点为 404.87 美元。该公司的市值为 1289.5 亿美元，市盈率为 40.11，市盈率增长比率为 1.97，贝塔系数为 0.85。该股票的 50 日移动平均线为 365.20 美元，200 日移动平均线为 367.71 美元。该公司的债务与股本比率为 0.66，速动比率为 1.21，流动比率为 1.89。</p>
</div><ul>
<li>Beware the Death Cross: 3 Stocks Triggering This Spooky Signal</li>
</ul>
<div class="lb-trans"><ul>
<li>当心死亡交叉：3 只触发这一可怕信号的股票</li>
</ul>
</div><p>Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating analysts' consensus estimates of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The company had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. During the same period last year, the company earned $4.01 earnings per share. The company's quarterly revenue was up 11.4% compared to the same quarter last year. As a group, research analysts expect that Stryker Corporation will post 13.47 EPS for the current year.</p>
<div class="lb-trans"><p>Stryker (NYSE:SYK - 获取免费报告) 最近在 1 月 29 日发布了季度财报。该医疗科技公司报告季度每股收益为 4.47 美元，超出分析师一致预期的 4.40 美元，超出幅度为 0.07 美元。Stryker 的股本回报率为 24.41%，净利润率为 12.92%。该公司季度收入为 71.7 亿美元，而分析师预期为 71.2 亿美元。去年同期，该公司每股收益为 4.01 美元。与去年同期相比，该公司的季度收入增长了 11.4%。整体而言，研究分析师预计 Stryker Corporation 本年度将发布 13.47 美元的每股收益。</p>
</div><h2>Stryker Dividend Announcement</h2>
<div class="lb-trans"><h2>Stryker 股息公告</h2>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 annualized dividend and a yield of 1.0%. Stryker's dividend payout ratio (DPR) is presently 41.90%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度股息，将于 4 月 30 日支付。3 月 31 日的股东将获得每股 0.88 美元的股息。该股息的除息日期为 3 月 31 日。这代表着年化股息为 3.52 美元，收益率为 1.0%。Stryker 的股息支付比率（DPR）目前为 41.90%。</p>
</div><h2>Insider Activity at Stryker</h2>
<div class="lb-trans"><h2>Stryker 的内部活动</h2>
</div><p>In other news, Director Ronda E. Stryker sold 250,000 shares of the company's stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the completion of the sale, the director directly owned 2,457,331 shares of the company's stock, valued at approximately $891,814,566.52. This represents a 9.23% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 5.90% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，董事 Ronda E. Stryker 于 2 月 4 日星期三出售了 250,000 股公司的股票，交易价格为每股平均 362.92 美元，总价值为 90,730,000.00 美元。出售完成后，该董事直接持有公司 2,457,331 股股票，价值约为 891,814,566.52 美元。这代表着其持股减少了 9.23%。该交易在向 SEC 提交的法律文件中披露，文件可通过此链接访问。公司内部人士持有公司 5.90% 的股票。</p>
</div><h2>Trending Headlines about Stryker</h2>
<div class="lb-trans"><h2>关于 Stryker 的热门头条</h2>
</div><p>Here are the key news stories impacting Stryker this week:</p>
<div class="lb-trans"><p>以下是本周影响 Stryker 的关键新闻故事：</p>
</div><ul>
<li>Positive Sentiment: Citi and some analysts view the pullback as a potential buying opportunity given Stryker’s fundamentals and upcoming catalysts — Citi put together a “90‑day catalyst watch” that sees upside despite the outage. Citi Sees Upside</li>
<li>Positive Sentiment: Technicals may offer support: commentators note shares became oversold after the sell‑off and found support at a prior level, suggesting a possible technical bounce for traders. Stock Of The Day: Where Is The Bottom For Stryker?</li>
<li>Neutral Sentiment: Stryker has publicly confirmed a cybersecurity incident and is investigating; the company is communicating updates as the situation evolves. Company Announcement</li>
<li>Neutral Sentiment: Reporting shows the attack is causing real operational disruption to order processing, manufacturing and shipments — facts investors must watch to judge duration and revenue impact. Reuters: Disruption Report</li>
<li>Negative Sentiment: Hackers claiming Iran linkage (group “Handala”) say the attack included destructive “wiper” activity and exfiltration of large volumes of data — allegations that raise the risk of extended downtime and regulatory/PR fallout. IBTimes: Hacker Claim</li>
<li>Negative Sentiment: Operational paralysis from the incident has already pressured the stock, with multiple outlets reporting multi‑percent intraday declines as orders and shipments stall. Yahoo: Shares Fall</li>
<li>Negative Sentiment: Social‑media driven selling amplified volatility — a viral Reddit thread and related headlines accelerated the recent drop, adding short‑term downside risk beyond fundamentals. 24/7 Wall St.: Reddit Impact</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：花旗和一些分析师认为此次回调是一个潜在的买入机会，考虑到史赛克的基本面和即将到来的催化剂——花旗制定了一个 “90 天催化剂观察”，认为尽管出现故障，仍有上涨空间。花旗看好前景</li>
<li>积极情绪：技术面可能提供支撑：评论人士指出，股票在抛售后变得超卖，并在之前的水平找到支撑，暗示交易者可能会出现技术性反弹。今日股票：史赛克的底部在哪里？</li>
<li>中性情绪：史赛克已公开确认发生网络安全事件，并正在调查；公司正在随着情况的发展进行更新沟通。公司公告</li>
<li>中性情绪：报告显示此次攻击对订单处理、制造和发货造成了实际的运营干扰——投资者必须关注这些事实，以判断持续时间和收入影响。路透社：干扰报告</li>
<li>消极情绪：声称与伊朗有关的黑客（“Handala” 组织）表示此次攻击包括破坏性的 “清除” 行为和大量数据的外泄——这些指控增加了延长停机时间和监管/公关后果的风险。国际财经时报：黑客声明</li>
<li>消极情绪：事件导致的运营瘫痪已经对股票施加压力，多家媒体报道订单和发货停滞，股价出现多个百分点的日内下跌。雅虎：股价下跌</li>
<li>消极情绪：社交媒体驱动的抛售加剧了波动性——一条病毒式传播的 Reddit 帖子及相关头条加速了近期的下跌，增加了超出基本面的短期下行风险。24/7 Wall St.：Reddit 影响</li>
</ul>
</div><h2>Stryker Profile</h2>
<div class="lb-trans"><h2>史赛克简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.</p>
<div class="lb-trans"><p>史赛克公司是一家全球医疗技术公司，设计、制造和销售广泛的产品和服务，供医院、外科医生办公室和其他医疗机构使用。其主要业务活动涵盖骨科（包括关节置换植入物、创伤和四肢产品）、外科设备和手术室技术（如可视化、导航和电动工具）、神经技术和脊柱解决方案，以及病人搬运和紧急医疗设备。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Stryker</li>
<li>A personal warning from Martin Weiss (Please read)</li>
<li>SpaceX IPO Confirmed: Claim Your Stake Today</li>
<li>Iran isn't the real war</li>
<li>This coin has everything going for it</li>
<li>Only 500 people today…</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票</li>
<li>马丁·韦斯的个人警告（请阅读）</li>
<li>SpaceX IPO 确认：今天认领你的股份</li>
<li>伊朗并不是真正的战争</li>
<li>这枚硬币一切都在向好发展</li>
<li>今天仅限 500 人…</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=SYK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Stryker Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在史赛克吗？</h2>
</div><p>Before you consider Stryker, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑史赛克之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而史赛克并不在名单上。</p>
</div><p>While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Comerica 银行削减了其在史赛克公司 $SYK 的持仓